Page last updated: 2024-08-16

resveratrol and Carcinoma, Papillary

resveratrol has been researched along with Carcinoma, Papillary in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Davis, FB; Davis, PJ; Lin, HY; Shih, A	1

Other Studies

1 other study(ies) available for resveratrol and Carcinoma, Papillary

Article	Year
Resveratrol induces apoptosis in thyroid cancer cell lines via a MAPK- and p53-dependent mechanism. The Journal of clinical endocrinology and metabolism, 2002, Volume: 87, Issue:3 Topics: Adenocarcinoma, Follicular; Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Papillary; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Humans; Mitogen-Activated Protein Kinases; Phosphorylation; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Resveratrol; RNA, Messenger; Stilbenes; Thyroid Neoplasms; Tumor Cells, Cultured; Tumor Suppressor Protein p53	2002

Article

Year

Resveratrol induces apoptosis in thyroid cancer cell lines via a MAPK- and p53-dependent mechanism.

The Journal of clinical endocrinology and metabolism, 2002, Volume: 87, Issue:3

Topics: Adenocarcinoma, Follicular; Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Papillary; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Humans; Mitogen-Activated Protein Kinases; Phosphorylation; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Resveratrol; RNA, Messenger; Stilbenes; Thyroid Neoplasms; Tumor Cells, Cultured; Tumor Suppressor Protein p53

2002